Works by Seow, C. H.

Results: 12

A framework for clinical care pathway renewal: an example from inflammatory bowel disease.

Published in:

BMC Medical Research Methodology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12874-025-02616-z

By:

Chappell, K. D.;
Olayinka, L.;
Sutton, R.;
Seow, C. H.;
deBruyn, J.;
van Zanten, S. V.;
Ma, C.;
Halloran, B.;
Dieleman, L. A.;
Wong, K.;
Panaccione, R.;
Kroeker, K. I.

Publication type:

Article

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1037, doi. 10.1111/apt.14368

By:

Mitrev, N.;
Vande Casteele, N.;
Seow, C. H.;
Andrews, J. M.;
Connor, S. J.;
Moore, G. T.;
Barclay, M.;
Begun, J.;
Bryant, R.;
Chan, W.;
Corte, C.;
Ghaly, S.;
Lemberg, D. A.;
Kariyawasam, V.;
Lewindon, P.;
Martin, J.;
Mountifield, R.;
Radford‐Smith, G.;
Slobodian, P.;
Sparrow, M.

Publication type:

Article

Editorial: different tests for different drugs in Crohn's disease, or different tests for different people?

Published in:

2017

By:

Seow, C. H.;
Panaccione, R.

Publication type:

Editorial

Editorial: is it time for therapeutic drug monitoring of anti- TNF agents during pregnancy? Maybe, maybe not. Author's reply.

Published in:

2017

By:

Seow, C. H.

Publication type:

Editorial

The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 10, p. 1329, doi. 10.1111/apt.14040

By:

Seow, C. H.;
Leung, Y.;
Vande Casteele, N.;
Ehteshami Afshar, E.;
Tanyingoh, D.;
Bindra, G.;
Stewart, M. J.;
Beck, P. L.;
Kaplan, G. G.;
Ghosh, S.;
Panaccione, R.

Publication type:

Article

Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 9, p. 1232, doi. 10.1111/apt.14016

By:

Ma, C.;
Fedorak, R. N.;
Kaplan, G. G.;
Dieleman, L. A.;
Devlin, S. M.;
Stern, N.;
Kroeker, K. I.;
Seow, C. H.;
Leung, Y.;
Novak, K. L.;
Halloran, B. P.;
Huang, V. W.;
Wong, K.;
Blustein, P. K.;
Ghosh, S.;
Panaccione, R.

Publication type:

Article

Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum?

Published in:

2017

By:

Shim, H. H.;
Seow, C. H.

Publication type:

Editorial

Commentary: detection of infliximab levels and anti-infliximab antibodies.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 1, p. 153, doi. 10.1111/apt.12107

By:

Seow, C. H.;
Panaccione, R.

Publication type:

Article

Management of Inflammatory Bowel Disease in Pregnancy: A Practical Approach to New Guidelines.

Published in:

Canadian Journal of Gastroenterology & Hepatology, 2016, p. 1, doi. 10.1155/2016/9513742

By:

Huang, V.;
Leung, Y.;
Nguyen, G. C.;
Seow, C. H.

Publication type:

Article

Towards Routine Non-invasive Monitoring of Disease Activity Using Gastrointestinal Ultrasound and Faecal Calprotectin in Pregnant Women With IBD.

Published in:

Journal of Crohn's & Colitis, 2020, v. 14, n. 12, p. 1790, doi. 10.1093/ecco-jcc/jjaa122

By:

Seow, C H;
Leung, Y;
Novak, K L

Publication type:

Article

Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 1, p. 20, doi. 10.1111/j.1365-2036.2009.04112.x

By:

SHALE, M. J.;
SEOW, C. H.;
COFFIN, C. S.;
KAPLAN, G. G.;
PANACCIONE, R.;
GHOSH, S.

Publication type:

Article

Reduction in surgical stoma rates in Crohn's disease: a population‐based time trend analysis.

Published in:

Colorectal Disease, 2019, v. 21, n. 11, p. 1279, doi. 10.1111/codi.14731

By:

Ma, C.;
Almutairdi, A.;
Tanyingoh, D.;
Seow, C. H.;
Novak, K. L.;
Lu, C.;
Panaccione, R.;
Kaplan, G. G.;
Kotze, P. G.

Publication type:

Article